FORM 8-K

Company

INTEGRATED BIOPHARMA INC

Filed

March 17, 2023

Period of Report

March 16, 2023

Accession Number

0001437749-23-007022

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →